Zenotech Laboratories Ltd. - Research Center
532039 ZENOTECH Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
61.03 |
61.03 |
61.03 |
61.03 |
61.03 |
Share application money
Preference share capital
Reserves & surplus
21.24 |
9.61 |
-12.62 |
-11.40 |
-22.13 |
Secured loans
Unsecured loans
Total
82.27 |
76.64 |
69.06 |
68.29 |
59.14 |
Gross block
106.78 |
105.13 |
101.48 |
69.52 |
59.05 |
Less : revaluation reserve
Less : accumulated depreciation
41.39 |
34.22 |
27.25 |
20.79 |
15.94 |
Net block
65.38 |
70.91 |
74.23 |
48.73 |
43.11 |
Capital work-in-progress
4.98 |
0.28 |
2.18 |
29.08 |
16.95 |
Investments
Current assets, loans & advances
30.51 |
22.90 |
9.43 |
7.74 |
24.52 |
Less : current liabilities & provisions
18.60 |
17.44 |
16.78 |
17.27 |
25.45 |
Total net current assets
11.91 |
5.45 |
-7.35 |
-9.53 |
-0.92 |
Miscellaneous expenses not written
Total
82.27 |
76.64 |
69.06 |
68.29 |
59.14 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
20.88 |
11.27 |
10.82 |
13.80 |
26.03 |
Number of equity sharesoutstanding (Lacs)
610.31 |
610.31 |
610.31 |
610.31 |
610.31 |